Amy C. Seila White

Statistics

Publications

Citations

906

H-Index

Active since

2011

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Amy C. Seila White is an author at Alnylam Pharmaceuticals (United States) specializing in molecular biology, small interfering ribonucleic acids (sirnas), and life sciences.

Publications per year

2011–2018

Publications

First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

Josep Tabernero, Geoffrey I. Shapiro, Patricia LoRusso et al. · Cancer Discovery · 2013 · 699 citations

Pharmacy, Oncology, Pharmaceutics +17

<i>Mir-290–295</i> deficiency in mice results in partially penetrant embryonic lethality and germ cell defects

Lea A. Medeiros, Lucas Dennis, Mark E. Gill et al. · Proceedings of the National Academy of Sciences · 2011 · 156 citations · Full text

Life Sciences, Developmental Biology, Genetics +17

Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo

Donald J. Foster, Scott Barros, Rick Duncan et al. · RNA · 2012 · 41 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +12

3′-Modification stabilizes mRNA and increases translation in cells

Christian M. Gampe, Amy C. Seila White, S Nayak Siva et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 10 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

1–4 of 4